Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.44 Trillion Total Companies: 1,738
Total Market Cap (USD)
$1.44 Trillion
Companies Listed
1,738
Largest Company
Arcus Biosciences Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 151 |
Arcus Biosciences Inc
NYSE:RCUS |
$1.72 Billion | $1.72 Billion | USA | $22.59 | +0.62% | -3.59% | 30.76 Million |
| 152 |
Definium Therapeutics, Inc.
NASDAQ:DFTX |
$1.70 Billion | $1.70 Billion | USA | $18.09 | -1.26% | -1.42% | 36.58 Million |
| 153 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
$1.67 Billion | $1.67 Billion | USA | $16.84 | +1.08% | -4.54% | 53.43 Million |
| 154 |
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
$1.64 Billion | CN¥12.00 Billion | China | CN¥70.79 | +2.71% | +1.03% | 56.83 Million |
| 155 |
Vericel Corp Ord
NASDAQ:VCEL |
$1.63 Billion | $1.63 Billion | USA | $32.50 | +0.65% | -4.75% | 11.55 Million |
| 156 |
Bavarian Nordic A/S
PINK:BVNKF |
$1.62 Billion | $1.62 Billion | USA | $20.71 | -4.12% | -14.53% | 2.22K |
| 157 |
Soleno Therapeutics Inc
NASDAQ:SLNO |
$1.61 Billion | $1.61 Billion | USA | $33.62 | +0.69% | -15.46% | 36.10 Million |
| 158 |
Genmab AS
NASDAQ:GMAB |
$1.61 Billion | $1.61 Billion | USA | $26.36 | -0.75% | -3.23% | 41.12 Million |
| 159 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
$1.60 Billion | $1.60 Billion | USA | $13.39 | +0.53% | -10.43% | 46.76 Million |
| 160 |
Tango Therapeutics Inc
NASDAQ:TNGX |
$1.59 Billion | $1.59 Billion | USA | $18.68 | +4.47% | +13.56% | 91.05 Million |
| 161 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
$1.57 Billion | $1.57 Billion | USA | $18.82 | -0.26% | -5.85% | 42.82 Million |
| 162 |
SOLENO THERAPEUT. DL-001
F:6XC |
$1.56 Billion | €1.52 Billion | Germany | €28.70 | -1.24% | -13.55% | 16.94K |
| 163 |
SHANGHAI JUNSHI BIO YC1
F:8SJ |
$1.55 Billion | €1.51 Billion | Germany | €2.16 | +2.86% | +8.54% | 27.00K |
| 164 |
Camurus AB
ST:CAMX |
$1.54 Billion | Skr17.29 Billion | Sweden | Skr471.00 | -0.04% | -1.46% | 4.60 Million |
| 165 |
Innoviva Inc
NASDAQ:INVA |
$1.53 Billion | $1.53 Billion | USA | $22.06 | -0.41% | -1.16% | 17.68 Million |
| 166 |
Inner Mongolia Furui Med Sci
SHE:300049 |
$1.53 Billion | CN¥11.20 Billion | China | CN¥54.17 | -0.20% | -2.76% | 130.83 Million |
| 167 |
ZYMEWORKS DL-00001
F:ZA8 |
$1.52 Billion | €1.48 Billion | Germany | €20.00 | +0.50% | -4.76% | 5.61K |
| 168 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
$1.51 Billion | $1.51 Billion | USA | $13.48 | +0.75% | -2.95% | 89.85 Million |
| 169 |
Longboard Pharmaceuticals Inc
NASDAQ:LBPH |
$1.50 Billion | $1.50 Billion | USA | $59.98 | +0.00% | +0.00% | 0.00 |
| 170 |
Novavax Inc
NASDAQ:NVAX |
$1.49 Billion | $1.49 Billion | USA | $10.64 | +5.56% | +0.85% | 120.40 Million |
| 171 |
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE |
$1.48 Billion | $1.48 Billion | USA | $50.39 | -1.70% | +11.83% | 12.66 Million |
| 172 |
Mind Medicine Inc
NASDAQ:MNMD |
$1.46 Billion | $1.46 Billion | USA | $15.38 | +2.40% | +9.62% | 51.88 Million |
| 173 |
BrightGene Bio Medical Technology C
SHG:688166 |
$1.46 Billion | CN¥10.70 Billion | China | CN¥44.72 | -2.66% | +11.05% | 199.15 Million |
| 174 |
Duality Biotherapeutics, Inc.
F:4ZB |
$1.45 Billion | €1.41 Billion | Germany | €32.20 | +5.23% | -5.29% | 1.06K |
| 175 |
89bio Inc
NASDAQ:ETNB |
$1.44 Billion | $1.44 Billion | USA | $14.84 | +0.00% | +0.27% | 140.50 Million |
| 176 |
APELLIS PHARMACT.DL-0001
F:1JK |
$1.44 Billion | €1.40 Billion | Germany | €15.66 | -2.04% | -4.48% | 4.95K |
| 177 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
$1.44 Billion | $1.44 Billion | USA | $28.37 | +1.83% | -0.70% | 29.32 Million |
| 178 |
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS |
$1.43 Billion | $1.43 Billion | USA | $25.02 | -2.76% | -8.15% | 27.15 Million |
| 179 |
Agios Pharm
NASDAQ:AGIO |
$1.43 Billion | $1.43 Billion | USA | $28.91 | +0.24% | +1.33% | 17.42 Million |
| 180 |
Nektar Therapeutics
NASDAQ:NKTR |
$1.42 Billion | $1.42 Billion | USA | $75.06 | +3.94% | +8.54% | 31.67 Million |
| 181 |
Vericel Corporation
F:ATQP |
$1.42 Billion | €1.38 Billion | Germany | €27.60 | -2.13% | -3.50% | 1.55K |
| 182 |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392 |
$1.39 Billion | CN¥10.20 Billion | China | CN¥39.75 | -0.23% | +4.52% | 67.57 Million |
| 183 |
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645 |
$1.38 Billion | CN¥10.14 Billion | China | CN¥29.59 | -4.64% | +5.34% | 303.01 Million |
| 184 |
ASCENTAGE PHARM. DL-0001
F:36X |
$1.38 Billion | €1.35 Billion | Germany | €5.10 | +5.37% | +10.87% | 17.68K |
| 185 |
Shanghai Junshi Biosciences Co. Ltd
PINK:SHJBF |
$1.38 Billion | $1.38 Billion | USA | $1.97 | +0.00% | +0.00% | 0.00 |
| 186 |
Anhui Anke BioTech Group
SHE:300009 |
$1.37 Billion | CN¥10.03 Billion | China | CN¥9.69 | +0.31% | +1.15% | 321.31 Million |
| 187 |
Stoke Therapeutics Inc
NASDAQ:STOK |
$1.34 Billion | $1.34 Billion | USA | $32.87 | -3.21% | -14.20% | 17.60 Million |
| 188 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
$1.31 Billion | $1.31 Billion | USA | $30.73 | +0.52% | -8.02% | 8.78 Million |
| 189 |
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
$1.29 Billion | $1.29 Billion | USA | $41.31 | -1.05% | +22.76% | 10.64 Million |
| 190 |
Ardelyx Inc
NASDAQ:ARDX |
$1.29 Billion | $1.29 Billion | USA | $5.83 | -0.17% | -5.51% | 90.09 Million |
| 191 |
Pharming Group NV
NASDAQ:PHAR |
$1.27 Billion | $1.27 Billion | USA | $15.49 | +0.39% | -3.13% | 555.41K |
| 192 |
Pharma Reaserch Prod Co Ltd
KQ:214450 |
$1.22 Billion | ₩1.79 Trillion | Korea | ₩320000.00 | +3.90% | +1.43% | 3.05 Million |
| 193 |
STOKE THERAPEUT.DL-001
F:0GT |
$1.22 Billion | €1.18 Billion | Germany | €29.00 | -7.05% | -1.36% | 3.46K |
| 194 |
KEYMED BIOSCIENCES -0001
F:64Z |
$1.22 Billion | €1.18 Billion | Germany | €5.75 | +0.00% | +2.68% | 4.36K |
| 195 |
ONESOURCE SPECIALTY PHARMA LTD
NSE:ONESOURCE |
$1.21 Billion | ₹104.67 Billion | India | ₹1486.30 | -0.46% | -1.89% | 6.55 Million |
| 196 |
RAPT Therapeutics Inc
NASDAQ:RAPT |
$1.20 Billion | $1.20 Billion | USA | $58.01 | +0.00% | +0.13% | 98.79 Million |
| 197 |
Pharma Mar SAU
PINK:PHMMF |
$1.19 Billion | $1.19 Billion | USA | $88.18 | +0.00% | -13.61% | 2.20K |
| 198 |
Biohaven Pharmaceutical Holding Co Ltd
NYSE:BHVN |
$1.18 Billion | $1.18 Billion | USA | $9.53 | -1.14% | -6.66% | 49.30 Million |
| 199 |
Capricor Therapeutics Inc
NASDAQ:CAPR |
$1.18 Billion | $1.18 Billion | USA | $31.19 | +2.06% | +1.83% | 34.50 Million |
| 200 |
AnaptysBio Inc
NASDAQ:ANAB |
$1.16 Billion | $1.16 Billion | USA | $67.29 | +3.87% | +12.71% | 12.37 Million |
| 201 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
$1.13 Billion | $1.13 Billion | USA | $21.29 | -0.33% | -0.19% | 163.18 Million |
| 202 |
DBV Technologies
NASDAQ:DBVT |
$1.13 Billion | $1.13 Billion | USA | $19.84 | -2.53% | -13.36% | 5.64 Million |
| 203 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
$1.11 Billion | $1.11 Billion | USA | $15.48 | +0.65% | -0.13% | 20.06 Million |
| 204 |
Wave Life Sciences Ltd
NASDAQ:WVE |
$1.10 Billion | $1.10 Billion | USA | $12.46 | +0.40% | -6.25% | 58.95 Million |
| 205 |
ATAI Life Sciences BV
NASDAQ:ATAI |
$1.10 Billion | $1.10 Billion | USA | $3.65 | +0.00% | -6.17% | 117.42 Million |
| 206 |
Oculis Holding AG Ordinary shares
NASDAQ:OCS |
$1.07 Billion | $1.07 Billion | USA | $26.92 | +3.46% | -1.82% | 9.02 Million |
| 207 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
$1.07 Billion | $1.07 Billion | USA | $11.19 | +0.27% | -4.36% | 28.95 Million |
| 208 |
Chengdu Olymvax Biopharmaceuticals Inc. A
SHG:688319 |
$1.06 Billion | CN¥7.77 Billion | China | CN¥31.31 | +0.06% | +6.93% | 152.32 Million |
| 209 |
Mesoblast Limited
F:LWB |
$1.06 Billion | €1.03 Billion | Germany | €1.21 | +0.83% | -2.42% | 66.19K |
| 210 |
Relay Therapeutics Inc
NASDAQ:RLAY |
$1.06 Billion | $1.06 Billion | USA | $10.26 | +1.28% | +1.18% | 60.37 Million |
| 211 |
CAPRICOR THERAP. DL-001
F:4LN2 |
$1.05 Billion | €1.02 Billion | Germany | €26.65 | +0.95% | +5.54% | 4.97K |
| 212 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
$1.03 Billion | $1.03 Billion | USA | $3.89 | -3.71% | -28.10% | 471.92 Million |
| 213 |
Beijing Hotgen Biotech Co Ltd
SHG:688068 |
$1.03 Billion | CN¥7.54 Billion | China | CN¥124.14 | -3.02% | -2.23% | 38.57 Million |
| 214 |
Galapagos NV
PINK:GLPGF |
$1.02 Billion | $1.02 Billion | USA | $23.01 | +0.00% | +0.00% | 0.00 |
| 215 |
InventisBio Co. Ltd. A
SHG:688382 |
$1.02 Billion | CN¥7.51 Billion | China | CN¥18.91 | -6.20% | -5.31% | 332.52 Million |
| 216 |
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
$1.02 Billion | CN¥7.51 Billion | China | CN¥14.10 | -0.91% | -0.35% | 219.79 Million |
| 217 |
EVEREST MED.LTD DL-0001
F:6HN |
$1.02 Billion | €993.68 Million | Germany | €4.04 | +2.02% | +6.32% | 6.99K |
| 218 |
Nuvation Bio Inc
NYSE:NUVB |
$1.02 Billion | $1.02 Billion | USA | $4.40 | -2.22% | -6.98% | 124.56 Million |
| 219 |
Dashenlin Pharm Grp Co Ltd
SHG:603233 |
$1.01 Billion | CN¥7.43 Billion | China | CN¥19.07 | -0.68% | -3.05% | 122.06 Million |
| 220 |
BioArctic AB (publ)
PINK:BRCTF |
$1.01 Billion | $1.01 Billion | USA | $18.10 | +0.00% | -0.11% | 1.20K |
| 221 |
IMMUNOCORE HLDGS ADS/1
F:6YG |
$1.01 Billion | €980.69 Million | Germany | €26.00 | +0.00% | -7.14% | 13.98K |
| 222 |
Nanobiotix
NASDAQ:NBTX |
$991.81 Million | $991.81 Million | USA | $32.08 | -5.65% | -20.06% | 1.23 Million |
| 223 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
$991.72 Million | $991.72 Million | USA | $15.45 | -1.72% | -2.77% | 27.74 Million |
| 224 |
Starlake Bioscience Co Inc Zhaoqing Guangdong
SHG:600866 |
$990.13 Million | CN¥7.26 Billion | China | CN¥8.05 | +0.25% | +6.06% | 912.39 Million |
| 225 |
Vir Biotechnology Inc
NASDAQ:VIR |
$973.78 Million | $973.78 Million | USA | $9.48 | -2.02% | -3.27% | 130.63 Million |
| 226 |
Mabwell (Shanghai) Bioscience Co. Ltd. A
SHG:688062 |
$949.30 Million | CN¥6.97 Billion | China | CN¥33.11 | -1.34% | +2.60% | 139.22 Million |
| 227 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
$948.49 Million | $948.49 Million | USA | $27.79 | +1.46% | -6.53% | 17.04 Million |
| 228 |
Oculis Holding AG
IC:OCS |
$944.65 Million | Ikr132.95 Billion | Iceland | Ikr3330.00 | -4.58% | -5.13% | 672.90K |
| 229 |
CARDERO RESOURCE
F:CR5 |
$942.95 Million | €918.63 Million | Germany | €23.00 | +3.60% | -1.71% | 3.86K |
| 230 |
Staidson Beijing Biopharma
SHE:300204 |
$942.81 Million | CN¥6.92 Billion | China | CN¥25.15 | -1.30% | -2.14% | 369.56 Million |
| 231 |
Chengdu Kanghua Biological Products
SHE:300841 |
$934.13 Million | CN¥6.85 Billion | China | CN¥60.51 | -2.37% | -2.01% | 40.14 Million |
| 232 |
Hugel Inc
KQ:145020 |
$929.14 Million | ₩1.36 Trillion | Korea | ₩250000.00 | +3.31% | +0.20% | 1.93 Million |
| 233 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
$918.47 Million | $918.47 Million | USA | $5.61 | +2.19% | +0.18% | 50.72 Million |
| 234 |
Pharvaris BV
NASDAQ:PHVS |
$901.02 Million | $901.02 Million | USA | $26.92 | -0.04% | +1.55% | 2.88 Million |
| 235 |
Hyundai Bioscience Co. Ltd
KQ:048410 |
$899.28 Million | ₩1.32 Trillion | Korea | ₩15540.00 | -1.33% | +0.84% | 163.88 Million |
| 236 |
MapLight Therapeutics, Inc. Common Stock
NASDAQ:MPLT |
$897.93 Million | $897.93 Million | USA | $17.87 | -5.40% | -9.70% | 3.81 Million |
| 237 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
$891.06 Million | $891.06 Million | USA | $9.70 | +4.64% | -1.32% | 49.70 Million |
| 238 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
$874.81 Million | $874.81 Million | USA | $8.89 | +2.18% | -1.77% | 27.33 Million |
| 239 |
Geron Corporation
NASDAQ:GERN |
$868.81 Million | $868.81 Million | USA | $1.62 | -1.82% | +0.00% | 426.78 Million |
| 240 |
BIOCYTOGEN PHARMA. H YC1
F:I54 |
$865.76 Million | €843.43 Million | Germany | €6.02 | -3.99% | -1.31% | 11.96K |
| 241 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
$859.93 Million | $859.93 Million | USA | $13.90 | +3.35% | -11.30% | 44.41 Million |
| 242 |
Chengzhi Shareholding Co Ltd
SHE:000990 |
$850.04 Million | CN¥6.24 Billion | China | CN¥9.81 | -1.21% | +9.36% | 1.03 Billion |
| 243 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
$849.05 Million | $849.05 Million | USA | $27.73 | +0.40% | -9.20% | 8.26 Million |
| 244 |
CureVac NV
NASDAQ:CVAC |
$842.41 Million | $842.41 Million | USA | $4.66 | -0.21% | +8.12% | 35.65 Million |
| 245 |
AbClon Inc
KQ:174900 |
$835.85 Million | ₩1.22 Trillion | Korea | ₩83000.00 | -6.21% | +31.54% | 9.83 Million |
| 246 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
$833.03 Million | $833.03 Million | USA | $15.06 | -9.31% | -5.91% | 45.55 Million |
| 247 |
MannKind Corp
NASDAQ:MNKD |
$822.37 Million | $822.37 Million | USA | $2.73 | -1.44% | +1.87% | 170.16 Million |
| 248 |
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497 |
$819.90 Million | CN¥6.02 Billion | China | CN¥15.35 | -3.03% | -2.23% | 416.61 Million |
| 249 |
Neuren Pharmaceuticals Limited
PINK:NURPF |
$819.58 Million | $819.58 Million | USA | $7.63 | +0.00% | +11.22% | 1.77K |
| 250 |
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX |
$816.19 Million | $816.19 Million | USA | $29.74 | -0.20% | +6.44% | 13.95 Million |
| 251 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
$808.83 Million | $808.83 Million | USA | $4.57 | +0.88% | -0.44% | 56.36 Million |
| 252 |
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
$802.48 Million | CN¥5.89 Billion | China | CN¥32.08 | -1.75% | -1.26% | 84.73 Million |
| 253 |
Kodiak Sciences Inc
NASDAQ:KOD |
$797.20 Million | $797.20 Million | USA | $23.85 | +2.32% | -7.27% | 13.76 Million |
| 254 |
Palvella Therapeutics, Inc
NASDAQ:PVLA |
$795.58 Million | $795.58 Million | USA | $120.80 | -4.17% | -11.63% | 9.31 Million |
| 255 |
PHARVARIS N.V. EO -12
F:9EN |
$790.20 Million | €769.82 Million | Germany | €23.00 | +4.55% | +3.60% | 2.51K |
| 256 |
HBM HLDGS LTD DL-000025
F:6XY |
$788.14 Million | €767.81 Million | Germany | €1.32 | -0.75% | +3.13% | 104.55K |
| 257 |
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
$784.18 Million | CN¥5.75 Billion | China | CN¥6.16 | -1.12% | +0.49% | 526.99 Million |
| 258 |
ITH0
F:ITH0 |
$780.92 Million | €760.78 Million | Germany | €64.50 | +1.57% | +4.03% | 6.23K |
| 259 |
Qurient Co. Ltd
KQ:115180 |
$778.59 Million | ₩1.14 Trillion | Korea | ₩45500.00 | -5.21% | +12.07% | 13.71 Million |
| 260 |
PATTIES FOODS - Frankfurt Stock Exchang
F:PH4 |
$777.98 Million | €757.92 Million | Germany | €0.77 | -0.65% | +9.29% | 54.40K |
| 261 |
SK Bioscience Co Ltd
KO:302440 |
$773.24 Million | ₩1.13 Trillion | Korea | ₩43700.00 | +2.34% | +5.43% | 3.64 Million |
| 262 |
GNI Group Ltd
F:3G6 |
$772.60 Million | €752.67 Million | Germany | €17.30 | -0.57% | -2.26% | 4.17K |
| 263 |
Omeros Corporation
NASDAQ:OMER |
$768.96 Million | $768.96 Million | USA | $11.27 | +1.17% | -0.18% | 18.10 Million |
| 264 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
$768.58 Million | $768.58 Million | USA | $12.07 | -1.23% | +3.61% | 37.39 Million |
| 265 |
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294 |
$768.06 Million | CN¥5.64 Billion | China | CN¥20.72 | -0.38% | -0.81% | 92.98 Million |
| 266 |
Anhui Huaheng Biotechnology Co. Ltd. A
SHG:688639 |
$759.43 Million | CN¥5.57 Billion | China | CN¥36.12 | +3.56% | +16.03% | 158.68 Million |
| 267 |
XERIS BIOPH.HOL. DL-0001
F:2B30 |
$759.00 Million | €739.42 Million | Germany | €4.70 | -0.21% | -4.63% | 33.36K |
| 268 |
Lin BioScience Inc.
TWO:6696 |
$751.39 Million | NT$24.86 Billion | Taiwan | NT$392.00 | -1.01% | -3.45% | 18.19 Million |
| 269 |
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO |
$745.09 Million | $745.09 Million | USA | $23.48 | +1.08% | -10.18% | 15.33 Million |
| 270 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
$743.29 Million | $743.29 Million | USA | $16.03 | -1.96% | -9.23% | 21.91 Million |
| 271 |
Abcellera Biologics Inc
NASDAQ:ABCL |
$738.02 Million | $738.02 Million | USA | $3.55 | -0.28% | +0.85% | 81.87 Million |
| 272 |
Yili Chuanning Biotechnology Co. Ltd. A
SHE:301301 |
$731.85 Million | CN¥5.37 Billion | China | CN¥11.46 | -0.87% | +4.47% | 461.17 Million |
| 273 |
Shanghai Medicilon Inc
SHG:688202 |
$730.34 Million | CN¥5.36 Billion | China | CN¥64.84 | -6.10% | -2.31% | 89.40 Million |
| 274 |
EYEPOINT PHARMAC. DL-01
F:PV3B |
$729.65 Million | €710.83 Million | Germany | €11.48 | +2.36% | -23.08% | 35.70K |
| 275 |
Verve Therapeutics Inc
NASDAQ:VERV |
$727.51 Million | $727.51 Million | USA | $11.13 | +0.00% | +1.64% | 98.92 Million |
| 276 |
HitGen Inc. A
SHG:688222 |
$724.85 Million | CN¥5.32 Billion | China | CN¥25.78 | -2.20% | -2.83% | 228.33 Million |
| 277 |
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SHG:688336 |
$723.02 Million | CN¥5.30 Billion | China | CN¥56.87 | -0.75% | +2.25% | 106.18 Million |
| 278 |
UroGen Pharma Ltd
NASDAQ:URGN |
$718.63 Million | $718.63 Million | USA | $18.59 | -0.75% | -6.63% | 21.65 Million |
| 279 |
Uniqure NV
NASDAQ:QURE |
$718.41 Million | $718.41 Million | USA | $15.62 | -2.01% | -13.17% | 126.01 Million |
| 280 |
CytomX Therapeutics Inc
NASDAQ:CTMX |
$718.16 Million | $718.16 Million | USA | $5.45 | -19.26% | +8.35% | 201.99 Million |
| 281 |
Astria Therapeutics Inc
NASDAQ:ATXS |
$718.13 Million | $718.13 Million | USA | $5784.30 | +45880.13% | +46026.79% | 20.97 Million |
| 282 |
CHA Biotech Co. Ltd
KQ:085660 |
$687.43 Million | ₩1.01 Trillion | Korea | ₩19200.00 | +0.95% | +4.80% | 17.27 Million |
| 283 |
Tyra Biosciences Inc
NASDAQ:TYRA |
$687.18 Million | $687.18 Million | USA | $37.92 | +2.46% | +12.36% | 28.72 Million |
| 284 |
Chimerix Inc
NASDAQ:CMRX |
$686.96 Million | $686.96 Million | USA | $8.54 | -0.12% | +0.12% | 42.97 Million |
| 285 |
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
$681.15 Million | $681.15 Million | USA | $19.32 | -0.41% | -1.93% | 14.15 Million |
| 286 |
KODIAK SCIENCES DL-0001
F:K27 |
$681.04 Million | €663.48 Million | Germany | €19.88 | -0.40% | -4.33% | 1.46K |
| 287 |
Aprilbio Co. Ltd.
KQ:397030 |
$678.93 Million | ₩994.09 Billion | Korea | ₩63700.00 | -3.04% | +3.75% | 11.10 Million |
| 288 |
Ventyx Biosciences Inc
NASDAQ:VTYX |
$669.96 Million | $669.96 Million | USA | $14.00 | +0.00% | +0.29% | 71.70 Million |
| 289 |
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658 |
$667.79 Million | CN¥4.90 Billion | China | CN¥17.98 | -1.64% | +0.62% | 200.81 Million |
| 290 |
VALNEVA SE SP.ADS/2
F:AYJ0 |
$667.13 Million | €649.92 Million | Germany | €8.95 | +1.70% | -3.76% | 22.99K |
| 291 |
ORIC PHARMAC.INC.DL-0001
F:4TZ |
$666.70 Million | €649.51 Million | Germany | €10.20 | -2.86% | -11.30% | 10.40K |
| 292 |
Arvinas Inc
NASDAQ:ARVN |
$665.05 Million | $665.05 Million | USA | $12.01 | -2.20% | -10.17% | 19.26 Million |
| 293 |
Basilea Pharmaceutica AG
PINK:BPMUF |
$661.96 Million | $661.96 Million | USA | $54.00 | +0.00% | +0.00% | 100.00 |
| 294 |
Immatics NV
NASDAQ:IMTX |
$649.88 Million | $649.88 Million | USA | $9.83 | +0.20% | -1.70% | 12.88 Million |
| 295 |
ABCELLERA BIOLOGICS
F:8QQ |
$640.32 Million | €623.81 Million | Germany | €3.05 | -0.03% | +6.15% | 14.74K |
| 296 |
Avid Bioservices Inc
NASDAQ:CDMO |
$636.51 Million | $636.51 Million | USA | $12.49 | +0.00% | +0.00% | 3.07 Million |
| 297 |
Xencor Inc
NASDAQ:XNCR |
$630.08 Million | $630.08 Million | USA | $11.74 | -2.41% | -1.10% | 17.69 Million |
| 298 |
Tourmaline Bio Inc.
NASDAQ:TRML |
$629.86 Million | $629.86 Million | USA | $47.98 | +0.00% | +0.02% | 13.86 Million |
| 299 |
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513 |
$623.86 Million | CN¥4.58 Billion | China | CN¥57.40 | -2.38% | +3.68% | 59.49 Million |
| 300 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
$620.30 Million | $620.30 Million | USA | $10.85 | +3.93% | -2.34% | 25.42 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries